Nonpeptidic inhibitors of human leukocyte elastase. 2. Design, synthesis, and in vitro activity of a series of 3-amino-6-arylopyridin-2-one trifluoromethyl ketones

J Med Chem. 1994 Sep 30;37(20):3303-12. doi: 10.1021/jm00046a015.

Abstract

A series of potent nonpeptidic inhibitors of the enzyme human leukocyte elastase (HLE) is reported. These inhibitors contain a 3-amino-2-pyridone ring as a central template in which the pyridone carbonyl and 3-position NH group are thought to form important hydrogen bonding interactions with the Val-216 residue of HLE. Substitution of the 6-position of the pyridone ring by various alkyl and aryl groups was found to afford increases in the in vitro potency of these inhibitors. A 6-position phenyl group, compound 10f, was found to result in a large increase in binding affinity, which was not obtained when the phenyl group was placed in either the 4- or 5-position of the molecule. Compound 10f was found to have good selectivity for HLE over other proteolytic enzymes, with the exception of bovine pancreatic chymotrypsin (BPC). Substitution of the 6-phenyl group in these molecules was found to decrease binding affinity for BPC without adversely affecting affinity for HLE.

Publication types

  • Comparative Study

MeSH terms

  • Acetamides / chemical synthesis*
  • Acetamides / chemistry
  • Acetamides / pharmacology
  • Amino Acid Sequence
  • Binding Sites
  • Drug Design
  • Humans
  • Hydrogen Bonding
  • Leukocyte Elastase
  • Models, Molecular
  • Molecular Sequence Data
  • Molecular Structure
  • Pancreatic Elastase / antagonists & inhibitors*
  • Pyridones / chemical synthesis*
  • Pyridones / chemistry
  • Pyridones / pharmacology
  • Structure-Activity Relationship
  • Valine / chemistry

Substances

  • 2-(3-((benzyloxycarbonyl)amino)-2-oxo-6-phenyl-1,2-dihydro-1-pyridyl)-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide
  • Acetamides
  • Pyridones
  • Pancreatic Elastase
  • Leukocyte Elastase
  • Valine